NCT00291785 - Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

September 30, 2008

Conditions

Colorectal Cancer

Interventions

DRUG

CT-2106

CT-2106 as 10 minute infusion on days 1, 15 \& 29 of each 42-day cycle

DRUG

Folinic acid

Folinic acid 200 mg IV 1 hour after CT-2106 infusion on days 1, 2, 15, 16, 29 and 30

DRUG

5-FU (fluorouracil)

5-FU following CT-2106 and folinic acid infusions @ 400 mg/m² IV bolus then 5-FU 600 mg/m² as a 22 hour IV infusion on Days 1, 2, 15, 16, 29, and 30.

Trial Locations (2)

"Policlinico Universitario A.Gemelli", Rome

Istituto Clinico Humanitas, Rozzano